Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q2 2023 Earnings

14AugConfirmed

Aug 22

Nov 22

Q4 2022

Q2 2023

-1.11

-0.74

-0.37

0

Details

Expected EPS

-0.92

Actual EPS

-1.11

Surprise EPS

-0.19

Surprise Percent

+20.65%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -1.11 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.